Delivery Order SPE2DB22D1106-SPE2DB24FDKV4

Award Date 11/6/23
Potential Completion Date 11/7/23
Potential Value $5.2K
Ultimate Awardee
Cencora, Inc.
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is for the delivery of Tetracaine 0.5% Eye, a pharmaceutical product, to the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at $3,320.01, was awarded to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract is a firm fixed-price delivery order with an ultimate completion date of April 23, 2024. Amerisourcebergen Drug Corp holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA...
This federal contract award, valued at $1,820.84, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is for the delivery of 4560036231 - Tetracaine 0.5% Eye Drops, 15 ml, with a completion date of February 24, 2023. The contract is a delivery order under a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued at $999,999,999 and...
This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,204.41, is for the delivery of 0.5% Tetracaine eye drops in 15 ml bottles. The award is a Firm Fixed Price Delivery Order with a completion date of January 23, 2024. The contract is not associated with any set-aside program and is part of a larger Indefinite Delivery Contract (IDC) valued at...
This is a federal contract award issued by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $11,960.76, is for the delivery of Tetracaine 0.5% Eye 1s, a pharmaceutical product. The contract is a Delivery Order with a Firm Fixed Price pricing type, and an ultimate completion date of November 8, 2024. AmerisourceBergen holds a significant Indefinite Delivery...
This is a delivery order contract awarded to Amerisourcebergen Drug Corp by the Defense Logistics Agency (DLA) Troop Support Medical on December 27, 2023. The contract is for the supply of 0.5% Tetracaine eye drops in 15ml bottles, with a ceiling value of $4,311.72 and a completion date of December 28, 2023. The contract is a firm fixed-price Delivery Order with no set-aside designation, indicating open competition. Amerisourcebergen is a major pharmaceutical distributor and healthcare solutions...
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $5,542.08 firm fixed-price delivery order covers the supply of Tetracaine 0.5% Steri-Unit Solution, a medical product used for topical anesthesia. This award is part of a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 that Cencora, Inc. holds with the DLA Troop Support Medical, which serves as the primary vehicle for the company to...
The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to supply 15 milliliter bottles of 0.5% tetracaine eye drops. The $2,308.80 contract has a completion date of January 2, 2024. Amerisourcebergen Drug Corp, a for-profit organization, is the prime contractor with no set-aside designation. The company has held previous indefinite delivery contracts with the Department of Justice Federal...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,101.01 firm fixed-price delivery order is for the supply of 4565786481 - Tetracaine 1% (20 mg/2 ml) vials, with a period of performance through September 13, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical division, which serves as a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The $3,933.14 firm fixed-price delivery order is for the supply of Tetracaine 0.5% Steri-Unit Solution, a pharmaceutical product. The contract does not have a set-aside designation. Amerisourcebergen holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for the company to deliver a...
This federal contract award, with an identification number of SPE2DB24D2205|SPE2DB24FDTRX, was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $6,815.26 firm fixed-price delivery order is for the supply of Tetracaine 0.5% Steri-Unit Solution, a pharmaceutical product. The contract has an ultimate completion date of May 7, 2024. Amerisourcebergen Drug Corp holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the...
  • SPE2DB22D1106
    Indefinite Delivery Contract
  • SPE2DB22D1106-SPE2DB24FDKV4
    Delivery Order

This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $5,192.13 firm fixed-price delivery order is for the provision of Tetracaine 0.5% eye drops, a pharmaceutical product used in medical settings. The contract has an ultimate completion date of November 7, 2023.

Amerisourcebergen Drug Corp is a major pharmaceutical distributor that holds several large Indefinite Delivery Contracts (IDCs) with the DLA, valued at up to $999,999,999.00 through 2026, and the Department of Justice Federal Bureau of Investigation, valued at up to $750,000 through 2024. These IDCs enable the efficient procurement of a comprehensive range of essential pharmaceutical products and medical supplies to support military, veteran, and federal healthcare programs. The current award does not have a set-aside designation, indicating open competition.

Generated 5/12/25, 10:37 AM